共 177 条
[1]
McGale P(2014)Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials Lancet 383 2127-2135
[2]
Taylor C(2019)Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1–2 N1 disease: an individual patient data analysis of three clinical trials Strahlenther Onkol 195 297-305
[3]
Correa C(2014)Locoregional recurrence risk for patients with T1,2 breast cancer with 1–3 positive lymph nodes treated with mastectomy and systemic treatment International journal of radiation oncology 89 392-398
[4]
Cutter D(2018)Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy Breast Cancer Res Treat 169 507-512
[5]
Duane F(2016)Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update J Clin Oncol 34 4431-4442
[6]
Omar A-R(2010)Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status Int J Rad Oncol 77 516-522
[7]
McBride A(2010)The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy Chin J Cancer 29 668-676
[8]
Allen P(2012)Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1–3 positive lymph nodes treated with modern systemic therapy Int J Rad Oncol 83 e577-581
[9]
Woodward W(2017)Incorporating risk factors to identify the indication of post-mastectomy radiotherapy in N1 breast cancer treated with optimal systemic therapy: a multicenter analysis in Korea (KROG 14–23) Cancer Res Treat 49 739-747
[10]
Kim M(2016)Postmastectomy radiotherapy benefit in Chinese breast cancer patients with T1–T2 tumor and 1–3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 cases Tumour Biol 37 6465-6475